cold challenge and augment endothelium-dependent vasodilation in cold sensitive 48 individuals. 49 Thirteen cold sensitive participants completed foot and hand cooling (separately, in 15 °C 50 water for 2 minutes) with spontaneous rewarming in 30°C air whilst skin temperature and (Fraser and Loftus, 1979) , in homeless individuals (Wrenn, 1991) and the elderly (Williams et 75 al., 2005) as well as in individuals working in cold environments, (Mills and Mills, 1993, 76 Cattermole, 1999, Golden et al., 2013). 77 Although severe NFCI can be debilitating, its pathophysiology is not fully understood and 78 therefore a definitive diagnostic tool is not available . Sub-clinical forms of 79 NFCI have also been characterised in individuals frequently exposed to cold conditions for result in reduced skin oxygen tension (Sheffield et al., 1996, Montgomery and Horwitz, 88 1950) and may put these individuals at greater risk of cold injury on subsequent cold 89 exposure (Cattermole, 1999) . 90 Animal models of NFCI have shown reduced levels of oxygen in the cooled tissues 91 (Montgomery et al., 1954) and that NFCI may be associated with a pro oxidant state (Geng 92 et al., 2015). Local cooling has been shown to inhibit endothelial nitric oxide synthase 93 (eNOS) as well as increase noradrenaline release (Hodges et al., 2006) . In addition, eNOS 94 activity has been shown to be positively associated with temperature (Kellogg et al., 2008 
Protocol

168
The participants attended the laboratory on three separate occasions at the same time of 169 day to reduce any circadian effects. On arrival at the laboratory, resting seated blood 170 pressure was measured using an automated blood pressure monitor (Omron HEM-705C, 171 Omron, Milton Keynes, UK) with the average of the final three measurements from the 
177
One and a half hours before arriving at the laboratory for the second and third visit, which 178 were separated by a wash-out period of at least 7 days, the participants consumed either 179 140 ml of concentrated beetroot juice (nitrate supplementation; 11.9 mmol nitrate; Beet it, 180 James White Drinks Ltd., Ashbocking, UK) or nitrate-depleted concentrated beetroot juice as 181 a placebo (Placebo; 0.02 mmol nitrate; Beet it, James White Drinks Ltd., Ashbocking, UK). 182 This dose has been used in previous studies (Shepherd et al., 2016) and results in peak 
Cold sensitivity test
191
The cold sensitivity test used in this study has been described in detail elsewhere (Eglin et 
Plasma nitrate and nitrite concentrations
Cold sensitivity test
339
There was no effect of nitrate supplementation on skin blood flow in the Great toe (F (2, 24) = Figure 3A ). Thumb skin blood flow also differed across time (F (2, 24) = 9.39, P = 0.001) 345 with CVC being lower at 5 and 10 min of rewarming compared to pre-immersion (P = 0.025 346 and P = 0.016 respectively; Figure 3C ).
347
There was no interaction between time and condition for skin blood flow in either the Great Table 1 ).
350
There was no effect of nitrate supplementation on skin temperature of the Great toe (F (2, 24) 351 = 0.70, P = 0.51), coldest toe (F (2, 24) = 0.81, P = 0.46), mean toe (F (2, 24) = 0.61, P = 0.55), or 352 mean finger (pre immersion: X 2 (2) = 2.57, P = 0.27, 5 minutes rewarming: X 2 (2) = 2.63, P = 353 0.27, or 10 minutes rewarming: X 2 (2) = 2.47, P = 0.29). temperature after 5 minutes of rewarming was colder than pre immersion (P = 0.028; P = 357 0.001 P < 0.001 respectively) but had returned to pre-immersion temperatures after 10 358 minutes (P = 0.318; P = 1.00; P = 1.00 respectively).
359
There was no interaction between time and condition for skin temperature (Great toe: F (4, 360 48) = 1.60, P = 0.19; coldest toe F (4, 48) = 1.81, P = 0.14; mean toe F (4, 48) = 0.81, P = 0.52) 361 when nitrate supplementation was compared to Placebo and Baseline (Figure 3 and Table   362 1). Nitrate supplementation 13.3 ± 2.1 4.8 ± 1.9 6.5 ± 1.7 10.0 ± 1.4
Thermal comfort Baseline 14.7 ± 1.9 9.5 ± 4.6 10.9 ± 4.4 13.1 ± 2.9
Placebo 13.4 ± 3.3 8.5 ± 3.0 10.9 ± 4.1 13.6 ± 3.1
Nitrate supplementation 13.4 ± 3.7 8.5 ± 3.8 9.9 ± 3. Placebo 12.7 ± 2.0 4.4 ± 1.5 5.9 ± 1.9 11.0 ± 2.1
Nitrate supplementation 11.8 ± 2.0 5.2 ± 1.8 6.5 ± 2.4 11.5 ± 2.1
Thermal comfort Baseline 14.6 ± 2.3 7.8 ± 3.8 8.5 ± 4.6 12.8 ± 2.3 Placebo 14.0 ± 3.2 8.7 ± 3.7 10.3 ± 4.0 13.5 ± 3.0
Nitrate supplementation 14.3 ± 3.1 7.9 ± 3.9 9.7 ± 4.1 13.2 ± 2.5 Pain Baseline 0.9 ± 0.9 0.7 ± 0.9 0.1 ± 0.3 0 ± 0 Placebo 0.9 ± 1.2 0.3 ± 0.6 0.0 ± 0.8 0 ± 0 Nitrate supplementation 0.8 ± 1.1 0.5 ± 1.0 0.1 ± 0.3 0 ± 0 expected skin temperature was different between skin sites, with the foot being 3.6°C 394 colder than the forearm and 2.6°C colder than the finger (F (2, 22) = 14.7, P < 0.001; Table 3 ).
395
Average CVC prior to iontophoresis was similar between conditions, for the forearm (n=12, reported. This was done in order to enable the primary outcomes to be measured at the 439 time of peak plasma nitrite concentration.
440
There was no effect of nitrate supplementation on peripheral blood flow and skin 441 temperature following exposure to a cold stimulus when compared to Placebo or Baseline
442
( Figure 3 and Table 1 ). As a consequence nitrate supplementation did not improve thermal 443 sensation, thermal comfort or reduce the associated pain with the cold stimulus when 444 compared to Placebo or Baseline (Table 2 ). These findings were in contrast to our previous 445 study which showed that organic nitrate (GTN spray) increased peripheral blood flow and 
